METHOD FOR CONTROLLING BACTERIAL BIOFILMS

Cinnamobactin and Use Thereof in Treatment of Bacterial Infection

ORAL SUPPLEMENT FOR CELLULAR METABOLIC FITNESS

METHOD FOR THE PRODUCTION OF RECOMBINANT AAV PARTICLE PREPARATIONS

NOVEL BACTERIOPHAGE COMPOSITIONS, FORMULATIONS AND METHODS OF MAKING AND USE

Novel Salmonella Enterica-Specific Bacteriophage OPT-SAL01, and Antibacterial Composition Comprising Same

STAPHYLOCOCCUS PHAGE COMPOSITIONS AND COCKTAILS THEREOF

SLC2A1 LNCRNA AS A BIOLOGIC AND RELATED TREATMENTS AND METHODS

ANTIBACTERIAL PHAGE, THERAPEUTIC COMPOSITION, BACTERICIDAL AGENT, FOOD, BACTERIA IDENTIFICATION KIT, THERAPEUTIC COMPOSITION MANUFACTURING METHOD, BACTERIA ELIMINATION METHOD, BACTERIA IDENTIFICATION METHOD, AND ANIMAL THERAPEUTIC METHOD

MYCOBACTERIOPHAGE COMPOSITIONS AND RELATED METHODS

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

NUCLEIC ACID CONSTRUCT AND USE THEREOF

METHODS AND COMPOSITIONS FOR PRODUCING A THERAPEUTIC FIELD EFFECT

SMAGP FUSION MOLECULES AND METHODS OF USE THEREOF

METHODS FOR TREATING AND PREVENTING DISEASES

SYSTEMS FOR PRODUCTION OF TRANSDUCING PARTICLES, METHODS, KITS, COMPOSITIONS AND USES THEREOF

Enhanced adoptive cell therapy

METHODS FOR TREATING CANCER WITH HYPERACTIVE ADAR ENZYMES

LENTIVIRAL VECTOR FORMULATIONS

COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC DISORDERS

SOLUTION FOR STORING A BACTERIOPHAGE

COMPOSITIONS AND METHODS FOR VIROTHERAPY

A CARBOMER HYDROGEL COMPRISING A PHAGE LYSATE FOR MAINTAINING NATURAL SKIN MICROFLORA AND SUPPRESSING PATHOGENIC BACTERIA

SOD1 DUAL EXPRESSION VECTORS AND USES THEREOF

M13 bacteriophages displaying peptide motifs targeting amyloid-beta, methods and uses thereof

G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)

USE OF APELIN FOR THE TREATMENT OF LYMPHEDEMA

BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

GUIDE RNAS, VECTORS, AND VIRIONS FOR TARGETING MUTATIONS IN THE PLN GENE

METHODS OF TRANSDUCTION USING A VIRAL VECTOR AND INHIBITORS OF ANTIVIRAL RESTRICTION FACTORS

METHODS OF TREATING BLADDER CANCER

COMPOSITIONS AND METHODS FOR BACTERIOPHAGE INFECTION OF STAPHYLOCOCCUS BACTERIA

COMPOSITIONS FOR TREATING XLMTM

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF ALZHEIMERS DISEASE

MICROHOMOLOGY MEDIATED REPAIR OF MICRODUPLICATION GENE MUTATIONS

Retroviral and Lentiviral Vectors

BACTERIA-TARGETING CAPSID PARTICLE, TREATMENT COMPOSITION, DISINFECTANT, FOOD, BACTERIA ELIMINATION METHOD, BACTERICIDAL METHOD, CORROSION PREVENTION METHOD, ANIMAL TREATMENT METHOD, GENE INTRODUCTION METHOD, BACTERIA FUNCTION ADDITION METHOD, METHOD FOR PRODUCING BACTERIA-TARGETING CAPSID PARTICLE, AND METHOD FOR PRODUCING NUCLEIC ACID FOR BACTERIA-TARGETING CAPSID PARTICLE

CHIMERIC AAV AND USES THEREOF

METHODS OF PREVENTING OR TREATING AN RNA VIRAL INFECTION IN A SUBJECT

CNS DELIVERY OF THERAPEUTIC AGENTS

REPLICATION-DEFECTIVE ARENAVIRUS VECTORS

MINIGENE THERAPY

POLYVALENT BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

GENE THERAPY FOR BVES-RELATED DISORDERS

MODIFIED CAPSID PROTEINS FOR ENHANCED DELIVERY OF PARVOVIRUS VECTORS

ANTIBIOTIC FREE TREATMENT OF MASTITIS

MODIFIED AAV CONSTRUCTS AND USES THEREOF

BROWN FAT-SELECTIVE ADIPOKINES

BACTERIOPHAGE PREPARATION IN THE FORM OF GEL TO PREVENT OR TREAT BACTERIAL INFECTIONS IN DAIRY CATTLE, ITS MANUFACTURING METHOD AND BACTERIOPHAGE STRAINS

Intrathecal Delivery of Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2

ADENO-ASSOCIATED VIRAL VECTORS FOR TARGETING BRAIN MICROVASCULATURE

METHOD FOR EXPRESSING A MUSCLE-SPECIFIC GENE AND CASSETTES FOR SAME

PSEUDOTYPED LENTIVIRAL VECTORS

MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY

CIRCULAR RNA CIRC-MAGI1 AND USES THEREOF

VIRAL PARTICLES RETARGETED TO SKELETAL MUSCLE

VESICULAR STOMATITIS VIRUS MARBURG VIRUS VACCINE

DUAL RECOMBINANT AAV8 VECTOR SYSTEM ENCODING ISOFORM 5 OF OTOFERLIN AND USES THEREOF

INTERFERON FOR THE TREATMENT OF BRACHYURY-ASSOCIATED CANCERS AND NEOPLASMS

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

COMPOSITION FOR IMPROVING DRUG SENSITIVITY OF ANTIBACTERIAL DRUG TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), COMPOSITION FOR TREATING OR PREVENTING MRSA INFECTION, AND COMPOSITION FOR REDUCING VIRULENCE OF MRSA

BACTERIOPHAGE THERAPY AGAINST ADHERENT-INVASIVE ESCHERICHIA COLI

COMPOSITION FOR REDUCING SIZE OR VOLUME OF TARGET TISSUE OR KIT INCLUDING SAME

SYNTHETIC VIRUSES

NOVEL EXCIPIENT COMPOSITION FOR MAINTAINING LONG-TERM DISTRIBUTION STORAGE STABILITY OF BACTERIOPHAGES

LENTIVIRAL VECTOR

METHODS AND COMPOSITIONS FOR TREATING NEGATIVE-SENSE SINGLE-STRANDED RNA VIRUS

Methods of Treating Cancer

USING INFECTIOUS NUCLEIC ACID TO TREAT CANCER

COMPOSITIONS AND METHODS FOR MUSCLE DISORDERS

FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATION

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING TEAR FILM COMPOSITION TO TREAT CORNEAL DEFECTS

THERAPEUTIC COMPOSITIONS AND METHODS

TREATING ORTHOPEDIC INJURY WITH A VECTOR DRIVING EXPRESSION OF ACID CERAMIDASE

COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2 POSITIVE CANCER

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCULAR DYSTROPHIES

THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE

TARGETING E COLI CELLS

PLANT-PRODUCED CHIMAERIC ORBIVIRUS VLPS

PHAGE AND ALLICIN COMPOSITION FOR INFECTION TREATMENT

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

RETROVIRAL VECTORS

PARTICLE COMPRISING A VIRUS

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONS

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

COMPOSITIONS AND METHODS OF USING TWO-PROMOTER VECTOR FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND CONDITIONS INCLUDING ECZEMA

BACTERIOPHAGE HAVING BACTERIOLYSIS ACTIVITY ON XANTHOMONAS SPP

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

MODIFIED AAV CAPSID PROTEIN AND USE THEREOF

COMPOSITION AND METHODS FOR MODULATION OF ELOVL2

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

CHIMERIC POXVIRUS COMPOSITIONS AND USES THEREOF

AUTOMATED PRODUCTION OF VIRAL VECTORS

MODIFIED VIRAL PARTICLES FOR GENE THERAPY

ENGINEERED VIRAL PARTICLES AND USES OF THE SAME

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS

Method of Generating Phage Clones with Expanded Activity

TREATING & PREVENTING E COLI INFECTIONS

CANCER IMMUNOTHERAPY USING VIRUS PARTICLES

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

BACTERIOPHAGES AND USE THEREOF FOR THE TREATMENT OR PREVENTION OF INFECTION CAUSED BY E. COLI

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

GENETICALLY MODIFIED PHAGES AND USES THEREOF

PRODUCTS OF MANUFACTURE AND METHODS TO ENRICH FOR AND ISOLATE VIRUSES OR PHAGES CAPABLE OF TARGETING SPECIFIC MICROBES

SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES

PHAGE DISPENSING SYSTEM

METHOD FOR SCREENING FOR MODIFICATIONS IN THE INFECTIVITY RANGE OF BACTERIOPHAGES DUE TO EPIGENETIC IMPRINTING

Burkholderia pseudomallei (Bp) phage vB BpP HN01 and use thereof

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

MIXTURE OF AT LEAST ONE BACTERIOPHAGE AND OF AT LEAST ONE YEAST AND METHOD FOR DRYING SAME

MEDICATION FOR INFLUENZA

STAPHYLOCOCCUS BACTERIOPHAGE AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF FABRY DISEASE

BACTERIOPHAGE PREPARATIONS AND METHODS OF USE

MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE

INTERFERON RECEPTOR ANTAGONISTS AND USES THEREOF

AAV Vectors Targeted to Oligodendrocytes

COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF PATHOGENIC ESCHERICHIA COLI

PHAGE THERAPY OF E COLI INFECTIONS

KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS

FORMULATION PROCESS FOR CPMV NANOPARTICLES

BACTERIOPHAGE THERAPY

SMALLPOX VACCINE FOR CANCER TREATMENT

Bacteriophage compositions and methods for treatment of bacterial infections

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INTESTINAL PARACELLULAR PERMEABILITY

AAV9-MEDIATED GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I

BACTERIOPHAGES FOR TREATMENT OF TUBERCULOSIS

IMMUNOGENIC COMPOSITION

COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND MAINTAINING HEALTHY SKIN

METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

BACTERIOPHAGES AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI

CONSTRUCTION AND APPLICATION OF RECOMBINANT H5N8 SUBTYPE AVIAN INFLUENZA VIRUS CARRYING MAPPLE FLUORESCENCE REPORTER GENE

METHOD FOR PURIFICATION OF BACTERIOPHAGE PARTICLES

ANTIBACTERIAL AND PROTECTIVE BACTERIOPHAGE FORMULATIONS AND METHODS FOR MAKING AND USING THEM

DEVICE AND METHODS FOR ACNE THERAPEUTICS: ANTIBACTERIAL BACTERIOPHAGES AND ENGINEERED LYSINS

RECOMBINANT BACULOVIRUSES, ALPHAVIRUS VIRUS-LIKE REPLICON PARTICLES PRODUCED THEREOF AND THEIR USES

COMBINATION THERAPIES COMPRISING A METTL3 INHIBITOR AND A FURTHER ANTICANCER AGENT

METHODS AND IMMUNOGENIC COMPOSITIONS RELATING TO HER2 WITH SELECTIVE SEQUENCE MODIFICATIONS

ARENAVIRUSES FOR USE IN THE TREATMENT AND/OR PREVENTION OF TUMORS AND METHOD FOR PRODUCING ARENAVIRUSES WITH (IM-PROVED) TUMOR-REGRESSION PROPERTIES

MULTIBIOTIC SUPPLEMENTS

AGENT FOR RESTORING VISUAL FUNCTION OR AGENT FOR PREVENTING DETERIORATION IN VISUAL FUNCTION

TREATMENT OF COMPLEMENT-MEDIATED DISORDERS

COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE

METHODS AND SYSTEMS FOR THE RAPID DETECTION OF SALMONELLA USING INFECTIOUS AGENTS

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION

INFLUENZA VIRUS DEFECTIVE INTERFERING PARTICLES FOR USE IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CORONAVIRIDAE INFECTION

COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE

NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS

METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION

NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION

COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE

BACTERIOPHAGE COMPOSITIONS FOR TREATING CLOSTRIDIUM PERFRINGENS INFECTIONS

METHODS TO ANALYZE HOST-MICROBIOME INTERACTIONS AT SINGLE-CELL AND ASSOCIATED GENE SIGNATURES IN CANCER

Bacteriophage compositions and methods for treatment of bacterial infections

CONTROLLED RELEASE OF BACTERIOPHAGE TO TREAT IMPLANT INFECTIONS

PSEUDOMONAS BACTERIOPHAGE AND USES THEREOF

METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

HYDROXYETHYCELLULOSE GEL COMPOSITION COMPRISING BACTERIOPHAGES

BACTERIOPHAGES PRODUCING HETEROLOGOUS BACTERIOCINS

COMPOSITIONS AND METHODS FOR TREATING PHENYLKETONURIA

LENTIVIRUS FOR GENERATING CELLS EXPRESSING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

NOVEL BACTERIOPHAGE HAVING ENTEROTOXIGENIC ESCHERICHIA COLI-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

INFLUENZA VIRUS DEFECTIVE INTERFERING PARTICLES FOR USE IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CORONAVIRIDAE INFECTION

COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE

NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

ESCHERICHIA COLI BACTERIOPHAGES AND USES THEREOF

MICROBIOME IDENTIFICATION AND BACTERIOPHAGE FORMULATIONS

FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE

Anticancer trail-targeted plant virus particles

PHAGE DISPENSING SYSTEM

BROWN FAT-SELECTIVE ADIPOKINES

BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

Bacteriophage composition and method of preventing bacterial infections in livestock

RETROVIRAL VECTORS

KLEBSIELLA BACTERIOPHAGE AND USES THEREOF

NANOSCALE COATINGS FOR ENCAPSULATION OF BIOLOGICAL ENTITIES

PROTOPARVOVIRUS AND TETRAPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY

COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE

METHODS AND MATERIALS FOR TREATING CANCER

NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

Cancer immunotherapy using virus particles

Compositions and methods for inhibiting the proliferation of enterotoxigenic

Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis

SYNERGISTIC COMPOSITION OF PHAGES AND ITS FORMATION METHOD

ENGINEERED VIRAL VECTOR REDUCES INDUCTION OF INFLAMMATORY AND IMMUNE RESPONSES

Compositions and methods for inhibiting the proliferation of enterotoxigenic

RETROVIRAL VECTORS

PHARMACEUTICAL COMBINATION PRODUCT COMPRISING A PROTOPARVOVIRUS AND AN ANTIVIRAL BENZIMIDAZOLE AND USES THEREOF FOR TREATING CANCER

BACTERIOPHAGE INFECTING DIABETES-INDUCING BACTERIUM AND USE THEREOF

HETEROGENEOUS MICROPARTICLES, AND SYSTEMS AND METHODS OF MAKING AND USE THEREOF

Bacteriophage and therapeutic agent for bacterial endophthalmitis

Automated production of viral vectors

Antibacterial composition and uses thereof

USE OF A BIRNAVIRUS ALONE OR IN COMBIMATION THERAPY FOR THE TREATMENT OF A DISEASE CAUSED BY A NIDOVIRUS

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

USE OF ANNEXIN V TO IMPROVE THE PURITY, SOLUBILITY AND LONG-TERM STABILITY OF PHAGE SUSPENSIONS

VIRAL VECTORS AND NUCLEIC ACIDS FOR USE IN THE TREATMENT OF ILD, PF-ILD AND IPF

GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS IIIB

NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS

SOD1 dual expression vectors and uses thereof

MODIFIED BACTERIOPHAGE

Method for Reducing the Population of at Least One Intestinal and/or Gastrointestinal Bacteria Species Comprising Bacteriophages, and Bacteriophages and the Use Thereof

PHAGE COMPOSITIONS FOR ESCHERICHIA COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF

CONJUGATED VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTI-TUMOR IMMUNE REDIRECTORS

FUSOBACTERIUM BACTERIOPHAGE AND USES THEREOF

THERAPEUTIC VIRAL MICROPARTICLES FOR PROMOTING STENT BIOFUNCTIONALITY AND WOUND HEALING IN VERTEBRATE INDIVIDUALS

LIVE BIOTHERAPEUTICS SECRETING SYNTHETIC BACTERIOPHAGES IN THE TREATMENT OF CANCER

MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE

DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEM THROUGH DOWNREGULATION OF CANCER-PRODUCED PREGNANCY SPECIFIC GLYCOPROTEIN

CANCER ERADICATING - BIO-NANOPARTICLES (CE-BNP)

PHAGE DELIVERY OF ANTI-INFLAMMATORY PEPTIDES

Modified viral particles for gene therapy

PHAGE AND TRANSDUCTION PARTICLES

Compositions and Methods of Treatment

Intrathecal Delivery of Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2

Compositions and methods for treating inflammatory disease

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

BACTERIOPHAGE VARIANTS HAVING EXTENDED HOST-RANGE, METHODS FOR PREPARATION AND USES THEREOF IN TRANSDUCING NUCLEIC ACIDS INTO HOSTS OF INTEREST

VECTORS AND METHODS FOR IN VIVO TRANSDUCTION

Lyophilized Formulations of AAV Drug Products

GENE THERAPIES FOR LYSOSOMAL DISORDERS

VIRAL VECTORS FOR TREATING PARKINSON'S DISEASE

GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS IIIA

NOVEL BACTERIOPHAGE EFFECTIVE FOR CONTROLLING SALMONELLA TYPHIMURIUM AND ITS DERIVED BIOFILM, AND AN ANTIBACTERIAL COMPOSITION COMPRISING THE SAME

THERAPEUTIC BACTERIOPHAGE COMPOSITIONS

Antibacterial formulation comprising a mixture of bacteriophages; use and method for preventing or treating diseases caused by salmonella spp. in farm animals by oral administration of the formulation

Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus

MULTIPLE HOST RANGE BACTERIOPHAGE WITH HYBRID TAIL FIBRES

AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM

Therapeutic bacteriophage compositions for treating infection

ONCOLYTIC VIRUS CARRYING E-CADHERIN AND USES THEREOF

Adeno-associated virus formulations

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

A COMPOSITION FOR REDUCING THE RISK OF URINARY TRACT INFECTION AND VAGINAL INFECTION IN WOMEN

METHODS FOR COMBINING ADOPTIVE T CELL THERAPY WITH ONCOLYTIC VIRUS ADJUNCT THERAPY

METHOD TO TREAT HEPATOMA WITH DENGUE VIRUSES AND A METHOD TO KILL HEPATOCELLULAR CARCINOMA TISSUES

DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF

METHODS FOR TREATING BACTERIAL INFECTIONS

ELIMINATION OF COLONIC BACTERIAL DRIVING LETHAL INFLAMMATORY CARDIOMYOPATHY

ADENO-ASSOCIATED VIRUS WITH ENGINEERED CAPSID

STABLE PSEUDOTYPED LENTIVIRAL PARTICLES AND USES THEREOF

Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin

AAV Vector for Disrupting Coagulation Factor-Related Gene on Liver Genome

IMMUNE INDUCER

GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA

PHAGE-MEDIATED DELIVERY OF GENES TO GUT MICROBIOME

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION

Smallpox vaccine for cancer treatment

CNS DELIVERY OF THERAPEUTIC AGENTS

CLOSED-ENDED, LINEAR, DUPLEX ADENOASSOCIATED VIRUS DNA, AND USES THEREOF

NANOPARTICLE-LOADED SILICIFIED CELLS, METHODS OF MAKING, AND METHODS OF USE

METHOD, COMPRISING BACTERIOPHAGES, FOR REDUCING THE POPULATION OF AT LEAST ONE ADIPOGENIC BACTERIAL SPECIES, AND BACTERIOPHAGES AND THE USE THEREOF

RECOMBINANT AAV VECTORS WITH ALTERED IMMUNOGENCITY AND METHODS OF MAKING THE SAME

SYSTEM AND METHOD FOR AEROSOL PARTICLE PRODUCTION OF SUBMICRON AND NANO STRUCTURED MATERIALS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS

COMPOSITIONS AND METHODS FOR PROMOTING CELLULAR METABOLIC FITNESS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS

METHODS FOR PURIFYING BACTERIOPHAGE AND PRODUCTS OF MANUFACTURE CONTAINING ENDOTOXIN-FREE BACTERIOPHAGE PREPARATIONS

BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION

COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

Bacteriophage Compositions And Methods Of Selection Of Components Against Specific Bacteria

Bacteriophage Cocktail-Containing Hydrogel Compositions and Methods of Production and Use Thereof

EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE TREATMENT OF NEUROPATHIC DISORDERS

BACTERIOPHAGE COMPOSITIONS AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS TO HER2 AND METHODS OF USE THEREOF

METHODS OF TREATING OR PREVENTING A VIRAL INFECTION USING BACTERIOPHAGES

PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND BACTERIOPHAGE APPLICATION DEVICE

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY

ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF

Reduction of Adsorption

M13 PHAGE BASED GENE THERAPY PLATFORM

DEFECTIVE INTERFERING PARTICLES

BIASED IL2 MUTEINS METHODS AND COMPOSITIONS

Methods and compositions for CNS delivery of iduronate-2-sulfatase

METHODS AND CONSTRUCTS FOR TRANSIENT PRODUCTION OF LENTIVIRAL VECTOR

Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof

Non-covalent loading of plant picovirus particles

COMPOSITIONS AND METHODS FOR CONTROLLED DELIVERY AND PROTECTION OF THERAPEUTIC AGENTS

DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS

PHAGE COMPOSITIONS COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF

Influenza virus mutants and uses therefor

MICROENCAPSULATION OF BACTERIOPHAGES AND RELATED PRODUCTS

COMPOSITIONS FOR THE TREATMENT OF DISEASE

COMPOSITIONS AND METHODS FOR TREATING ANEMIA

CRISPR CAS SYSTEMS AND LYSOGENY MODULES